Transplant-related strongyloidiasis in solid organ transplant recipients in Saudi Arabia and the Gulf Cooperation Council countries
Author(s) -
Fatehi Elzein,
Hamad Al-Bahili,
Abdelkarim Bahloul,
Thamer Alonazi,
Adnan Alghamdi,
Eid Alsufyani,
Abdullatif Musa,
Mohammed Alsaeed
Publication year - 2020
Publication title -
international journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.278
H-Index - 89
eISSN - 1878-3511
pISSN - 1201-9712
DOI - 10.1016/j.ijid.2020.01.032
Subject(s) - strongyloidiasis , medicine , strongyloides , mortality rate , disease , transmission (telecommunications) , bacteremia , pediatrics , intensive care medicine , surgery , immunology , antibiotics , helminths , microbiology and biotechnology , electrical engineering , biology , engineering
Strongyloidiasis is a devastating disease with a mortality rate exceeding 50% in immunocompromised patients. The disease usually results from reactivation of a latent infection in a transplant patient. Alternatively, donor-derived transmission of Strongyloides may occur.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom